The Importance of Early Diagnosis and Intervention in Myopic CNV

Select a video to view:

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Powerful, rapid and long-term efficacy across indications

by Pravin U. Dugel MD

Pravin U. Dugel, MD, discusses the current evidence that demonstrates the rapid and long-term outcomes that are achievable with ranibizumab across multiple retinal disorders including CNV. Dr. Dugel also comments on recent long-term data showing visual acuity gains can be maintained up to 7 years in nAMD patients.

763 video views since . 1,564 total series views.

Novartis Pharma AG

CH-4002 Basel, Switzerland ©2014 Novartis Pharma AG Dec 2014 GLRET/LUC/0274